Considered and approved and taken on records the Standalone and Consolidated Audited Financial Results along with the Statement of Assets and Liabilities and the Audit Report for the half ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shivam Chemicals Ltd reported strong double-digit growth for FY2026. Consolidated revenue grew 26.8% to ₹2,842.26 crore (from ₹2,241.33 crore), while standalone revenue rose 30% to ₹2,695.56 crore. Consolidated PAT surged 195.7% to ₹61.89 crore (from ₹20.93 crore) and standalone PAT increased 83.2% to ₹47.11 crore. EPS on consolidated basis improved to ₹3.64 from ₹1.26. An exceptional item of ₹16.82 lakh was recorded. Auditors issued an unmodified opinion. However, the company faced significant negative operating cash flow — consolidated at negative ₹598.59 lakh and standalone at negative ₹684.78 lakh. Short-term borrowings nearly doubled to ₹1,818.64 lakh on consolidated basis (from ₹1,036.01 lakh), indicating increased reliance on debt. Cash and cash equivalents declined sharply to ₹39.24 lakh consolidated and ₹11.79 lakh standalone.
Strong topline and bottomline growth is positive, but the large negative operating cash flow and near-doubling of short-term debt raise concerns about cash conversion quality and liquidity risk, which investors should monitor closely.